Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial (Pyogenic) Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial (Pyogenic) Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial (Pyogenic) Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe,... Research Beam Model: Research Beam Product ID: 153544 2500 USD New
Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014

 
  • Category : Pharmaceuticals
  • Published On : November  2014
  • Pages : 100
 
 
Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial (Pyogenic) Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial (Pyogenic) Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial (Pyogenic) Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bacterial (Pyogenic) Meningitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bacterial (Pyogenic) Meningitis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
GlaxoSmithKline plc 40
Clinical Trial Overview of GlaxoSmithKline plc 40
Sanofi 42
Clinical Trial Overview of Sanofi 42
Serum Institute of India Limited 43
Clinical Trial Overview of Serum Institute of India Limited 43
Baxter International Inc. 44
Clinical Trial Overview of Baxter International Inc. 44
JN-International Medical Corporation 45
Clinical Trial Overview of JN-International Medical Corporation 45
Beijing Minhai Biotechnology Co., Ltd 46
Clinical Trial Overview of Beijing Minhai Biotechnology Co., Ltd 46
Abbott Laboratories 47
Clinical Trial Overview of Abbott Laboratories 47
Clinical Trial Overview of Top Institutes / Government 48
University of Oxford 48
Clinical Trial Overview of University of Oxford 48
Assistance Publique - Hopitaux de Paris 49
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 49
Universitas Padjadjaran 50
Clinical Trial Overview of Universitas Padjadjaran 50
Chhatrapati Shahuji Maharaj Medical University 51
Clinical Trial Overview of Chhatrapati Shahuji Maharaj Medical University 51
Health Protection Agency 52
Clinical Trial Overview of Health Protection Agency 52
The National Institute of Allergy and Infectious Diseases 53
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 53
Bio-Manguinhos 54
Clinical Trial Overview of Bio-Manguinhos 54
University of Malawi 55
Clinical Trial Overview of University of Malawi 55
National Institute for Public Health and the Environment 56
Clinical Trial Overview of National Institute for Public Health and the Environment 56
Epicentre Biotechnologies 57
Clinical Trial Overview of Epicentre Biotechnologies 57
Five Key Clinical Profiles 58
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 100
List Of Tables
List of Tables
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 33
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 37
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 40
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 42
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Serum Institute of India Limited, 2014* 43
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014* 44
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by JN-International Medical Corporation, 2014* 45
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Minhai Biotechnology Co., Ltd, 2014* 46
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 47
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 48
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 49
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitas Padjadjaran, 2014* 50
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chhatrapati Shahuji Maharaj Medical University, 2014* 51
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Protection Agency, 2014* 52
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 53
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Manguinhos, 2014* 54
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Malawi, 2014* 55
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute for Public Health and the Environment, 2014* 56
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Epicentre Biotechnologies, 2014* 57
List Of Figures
List of Figures
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bacterial (Pyogenic) Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bacterial (Pyogenic) Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bacterial (Pyogenic) Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 99